openPR Logo
Press release

Myasthenia Gravis Market to Witness an Upsurge in Growth by 2034, Examines DelveInsight

04-30-2024 09:42 PM CET | Health & Medicine

Press release from: ABNewswire

Myasthenia Gravis Market to Witness an Upsurge in Growth by 2034,

DelveInsight's "Myasthenia Gravis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the myasthenia gravis, historical and forecasted epidemiology and the Myasthenia Gravis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Key Takeaways from the Myasthenia Gravis Market Report

* The increase in Myasthenia Gravis Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
* As per DelveInsight analysis, the Myasthenia Gravis Market is anticipated to witness growth at a considerable CAGR.
* The leading Myasthenia Gravis Companies working in the market include Viela Bio, UCB Pharma, Momenta Pharmaceuticals, Sanofi, Regeneron Pharmaceuticals, Ra Pharmaceuticals, Hoffmann-La Roche, Alexion Pharmaceuticals, Nanjing IASO Biotherapeutics, Cabaletta Bio, CytoDyn, Ahead Therapeutics, Toleranzia, Rallybio, and many others.
* Promising Myasthenia Gravis Therapies in the various stages of development include Satralizumab, Tacrolimus capsule, ARGX-113, and others.
* April 2024:- UCB Biopharm SRL- An Open-label, Crossover Study to Evaluate Rozanolixizumab Self-administration by Study Participants With Generalized Myasthenia Gravis. The purpose of this study is to evaluate the ability of study participants with generalized Myasthenia Gravis (gMG) to successfully self-administer rozanolixizumab after training in the self-administration technique using the syringe driver and manual push methods.
* April 2024:- Janssen Research & Development, LLC- An Open-Label Uncontrolled Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Activity of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis. The purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myasthenia Gravis Market to Witness an Upsurge in Growth by 2034, Examines DelveInsight here

News-ID: 3481178 • Views:

More Releases from ABNewswire

Best ADU Builders in St. Petersburg, FL (2026 Review): Zoning, Cost & Contractor Selection
Best ADU Builders in St. Petersburg, FL (2026 Review): Zoning, Cost & Contractor …
A 2026 market review examines how homeowners in St. Petersburg, Florida are evaluating ADU builders under stricter zoning and permitting enforcement. The report compares contractor types, highlights common project failures, and explains why design-build firms are increasingly preferred for compliant accessory dwelling unit construction. ST. PETERSBURG, FL - January 13, 2026 - As demand for accessory dwelling units (ADUs) continues to rise across St. Petersburg and Pinellas County, homeowners are facing
How to Draw a Corgi: A Creative Guide to Relaxation and Mindfulness
How to Draw a Corgi: A Creative Guide to Relaxation and Mindfulness
New Book Confessions of a Corgi Doodler Turns Simple Sketches Into a Philosophy for Creative Living MARIETTA, GA - The new book Confessions of a Corgi Doodler [https://www.amazon.com/Confessions-Corgi-Doodler-Nancy-Kondos/dp/1966972717/ref=tmm_pap_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.eK5vqZKYyVTf8-wHEYO8Bw.pJTT3UgaTroxKgcIHzvQiAWCz1FNpLKHBjvk9qWGepE&qid=1765308929&sr=1-1] begins with a single instruction: lose your predictions. Let the pen dance. What follows is not just a guide to drawing the charming, short legged dog, but a series of illustrated revelations on creativity itself. Published by Author's Tranquility Press, this volume by
Amidst the Silence of Loss A New Voice Emerges
Amidst the Silence of Loss A New Voice Emerges
The new book "Live Again: A Widow's Guide to Healing and Recovery" by Alene Maag offers a compassionate and practical resource for the journey through widowhood. MARIETTA, GA - In the quiet aftermath of a spouse's death, a crushing duality descends: an ocean of private grief and a mountain of public, practical demands. This isolating space now has a thoughtful new companion. "Live Again: A Widow's Guide to Healing and Recovery
Sams Gas Kicks Off the New Year by Helping Central Florida Residents Plan for Reliable Propane Delivery
Sams Gas Kicks Off the New Year by Helping Central Florida Residents Plan for Re …
As Central Florida residents begin a new year, Sams Gas is encouraging homeowners and businesses to start 2026 with dependable propane delivery and proactive energy planning. January is an ideal time to review propane usage, schedule routine deliveries, and ensure tanks are prepared for cooler winter nights and the months ahead. ORLANDO, FL - January 13, 2026 - As Central Florida residents begin a new year, Sams Gas is encouraging homeowners

All 5 Releases


More Releases for Myasthenia

Myasthenia Gravis (MG) Treatment Market: Insights and Trends
The Global Myasthenia Gravis (MG) Treatment Market is experiencing notable growth, driven by increasing awareness of the disease and advancements in treatment options. Myasthenia Gravis is a chronic autoimmune disorder that leads to varying degrees of muscle weakness, and effective management is crucial for improving patient quality of life. With ongoing research and development in treatment modalities, the market is poised for significant expansion over the coming years. Market Size and Growth: The
Myasthenia Gravis Market | Rising Prevalence Of Neuromuscular Disorders
According to Precision Business Insights (PBI), the latest report, the Myasthenia Gravis market is expected to be valued at USD 1,734.6 million in 2022, growing at an 8.1% CAGR from 2022 to 2028. The primary driver of the expansion of the global Myasthenia Gravis market increasing prevalence of neuromuscular disorders, and rising awareness about effective treatment. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/myasthenia-gravis-market/ Medication Segment to Dominate the Myasthenia
Myasthenia Gravis - Drug Pipeline Landscape, 2022
Myasthenia gravis is a chronic autoimmune neuromuscular condition that causes muscle weakness and severe fatigue. It causes weakness in the skeletal muscles, which are the muscles your body uses for movement. Myasthenia gravis is caused by a breakdown in the normal communication between nerves and muscles. Healthcare professional checks neurological health by testing reflexes, muscle strength, muscle tone etc. Ice pack test, antibody tests, imaging scans and electromyogram can also be
Myasthenia Gravis Industry Report Analysis By opportunities
Stratistics MRC's Myasthenia Gravis Market report provides readers with an understanding of market details, overview, drivers and segmentation with types. Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis. Browse complete "Myasthenia Gravis Market" report with TOC
Myasthenia Gravis Industry Report Analysis By opportunities
Stratistics MRC's Myasthenia Gravis Market report provides readers with an understanding of market details, overview, drivers and segmentation with types. Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis. Browse complete "Myasthenia Gravis Market" report with TOC
Global Myasthenia Gravis Industry Analysis By Geography
Stratistics MRC's Myasthenia Gravis Market report explains company profiling, key segments, market trends, top players and regional, country-level segments. Myasthenia gravis is a chronic autoimmune neuromuscular disorder that is characterized by variable weakness of the voluntary muscle groups. Muscles that observe eye movement, shoulder & facial muscles, breathing & swallowing and eye lids are the ones that are regularly impacted in myasthenia gravis. Browse complete "Myasthenia Gravis Market" report with TOC @